PDCD1 and non-small cell lung carcinoma: CyTOF analysis was performed on 34 peripheral blood mononuclear cells (PBMCs) samples from a prospective discovery cohort comprising 20 patients with NSCLC treated with PD-1 inhibitor monotherapy to perform an in-depth evaluation of the immunological profiles of PBMCs in NSCLC (Fig. 1a).